跳至主要内容
临床试验/KCT0000831
KCT0000831已完成未知

Dendritic cell-based immunotherapy for progressed or relapsed solid tumor (breast cancer,ovarian cancer, renal cell carcinoma) patient-Phase 2 clinical study.

Asan Medical Center0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 69(Year)(—)
性别
Female

入选标准

  • Age: 20~69 years old
  • -Systemic condition: ECOG<3
  • -Pregressed disease patients
  • -Disease status : patients with metastatic ovarian cancer at diagnosis or relapsed after diagnosis
  • -Pt with proper kidney, liver and bone marrow functions
  • 1) Hb 10.0g/dl, WBC 3,500/ul, PLT 100,000/ul
  • 2) Serum Creatinin level < 1.25 times of normal healthy people
  • 3) Serum SGOT/SGPT level < 3 times of normal healthy people
  • -Signed informed consent, volutarily

排除标准

  • -Pts with active infection
  • -Defects on heart, liver, lung, brain and/or kidney function.
  • -Pregnant or women with possibility of pregnancy (positive with test.)

研究者

相似试验

进行中(未招募)
1 期
Dendritic cell-based immunotherapy for advanced solid tumours of children and young adultsChildren and young adults with advanced solid tumours: relapsed or metastatic sarcomas or central nervous system tumours.
EUCTR2013-003632-71-ESClínica Universidad de Navarra/Universidad de Navarra10
尚未招募
不适用
Dendritic cell-based immunotherapy combined with low-dose cyclophosphamide in patients with malignant pleural mesotheliomamesothelioma10035597
NL-OMON32554Erasmus MC, Universitair Medisch Centrum Rotterdam10
进行中(未招募)
不适用
Dendritic cell-based Immunotherapy in patients with primary glioblastoma multiformeNeoplasms
KCT0000280Bundang CHA General Hospital13
已完成
1 期
Dendritic cell-based tumor-specific immunotherapy against malignant brain tumor - Phase I clinical trialMalignant brain tumor (malignant glioma)
JPRN-UMIN000000914Shizuoka Cancer Center12
进行中(未招募)
1 期
Personalized dendritic cell-based immune therapy for improving treatment of children with brain (stem) tumorsChildhood high-grade glioma and diffuse intrinsic pontine gliomaMedDRA version: 20.0Level: LLTClassification code 10046859Term: VaccinationSystem Organ Class: 100000004865MedDRA version: 20.0Level: PTClassification code 10006143Term: Brain stem gliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10080666Term: Diffuse intrinsic pontine gliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2020-004125-23-BEAntwerp University Hospital10